Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduced platelet aggregation in hemolytic-uremic syndrome

B S Kaplan, J S Fong

    Thrombosis and Haemostasis
    |June 18, 1980
    PubMed
    Summary

    Platelet aggregation is reduced in patients with hemolytic-uremic syndrome (HUS) when platelet counts are low. Normal aggregation responses return as platelet counts normalize, indicating a temporary impairment during active HUS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Haemolytic uraemic syndrome associated with Pseudomonas aeruginosa sepsis.

    Journal of medical microbiology·2013
    Same author

    Dent disease presenting as partial Fanconi syndrome and hypercalciuria.

    Kidney international·2008
    Same author

    An update on the hemolytic uremic syndrome.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Glomerular epithelial cell arachidonate metabolism in Shiga toxin hemolytic uremic syndrome.

    Kidney international·2001
    Same author

    HUS or not HUS?

    Pediatric nephrology (Berlin, Germany)·2001
    Same author

    Improve survival with plasma exchange thrombotic thrombopenic purpura-hemolytic uremic syndrome.

    The American journal of medicine·2001

    Area of Science:

    • Hematology
    • Nephrology
    • Pediatric Nephrology

    Background:

    • Hemolytic-uremic syndrome (HUS) is a serious condition characterized by hemolytic anemia, thrombocytopenia, and acute kidney injury.
    • Platelet dysfunction may contribute to the pathophysiology of HUS, but its specific role requires further elucidation.

    Purpose of the Study:

    • To investigate platelet aggregation function in patients with HUS during active disease and after recovery.
    • To determine if reduced platelet counts or an intrinsic platelet defect underlies impaired aggregation in HUS.

    Main Methods:

    • Studied platelet aggregation in three HUS patients with low (<100,000/mm3) and normalized platelet counts.
    • Tested aggregation responses to epinephrine, adenosine diphosphate (ADP), and collagen.
    • Utilized platelet-rich plasma and platelet-poor plasma from patients and normal subjects for comparative analysis.

    Main Results:

    • Platelet aggregation was absent in response to epinephrine during thrombocytopenia in HUS patients.
    • Normal aggregation responses were observed once platelet counts normalized.
    • Dilution experiments confirmed that the reduced aggregation was not solely due to low platelet counts but potentially an intrinsic issue during active HUS.

    Conclusions:

    • Platelet aggregation is significantly impaired in the early, thrombocytopenic phase of hemolytic-uremic syndrome.
    • This impairment appears to be multifactorial, involving both reduced platelet counts and potential functional deficits during active HUS.

    Related Experiment Videos